These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11338500)

  • 1. [Immunosuppressive effects of pathogenic gram-negative bacteria].
    Vorob'ev AA; Borisova EV; Molozhavaia OS; Borisov VA
    Vestn Ross Akad Med Nauk; 2001; (2):21-5. PubMed ID: 11338500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R-form lipopolysaccharides (LPS) of Gram-negative bacteria as possible vaccine antigens.
    Stanislavsky ES; Makarenko TA; Kholodkova EV; Lugowski C
    FEMS Immunol Med Microbiol; 1997 Jul; 18(3):139-45. PubMed ID: 9271164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An antigenic analysis and the protective properties of the R-form lipopolysaccharides of gram-negative bacteria].
    Stanislavskiĭ ES; Makarenko TA; Kholodkova EV; Lugowski C
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):52-6. PubMed ID: 9783402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
    Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gram-negative virulent bacterial lipopolysaccharide: role in infection and immunity].
    Vorobév AA; Borisova EV; Borisov VA
    Vestn Ross Akad Med Nauk; 1997; (3):10-3. PubMed ID: 9181847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteria.
    Freudenberg MA; Merlin T; Gumenscheimer M; Kalis C; Landmann R; Galanos C
    Microbes Infect; 2001; 3(14-15):1213-22. PubMed ID: 11755409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive properties of virulent Shigella strains].
    Borisova EB
    Mikrobiol Z; 2000; 62(1):64-72. PubMed ID: 11300086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response of non-pathogenic gram(+) and gram(-) bacteria in inductive sites of the intestinal mucosa study of the pathway of signaling involved.
    Dogi CA; Weill F; Perdigón G
    Immunobiology; 2010; 215(1):60-9. PubMed ID: 19250703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of equine anti-lipopolysaccharide hyperimmune plasma: binding to lipopolysaccharide and bactericidal activity against gram-negative bacteria.
    Wells MT; Gaffin SL; Gregory M; Coovadia Y
    J Med Microbiol; 1987 Nov; 24(3):187-96. PubMed ID: 3669052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improved method of lipopolysaccharide isolation from gram-negative bacteria].
    Kul'shin VA; Iakovlev AP; Avaeva SN; Dmitriev BA
    Mol Gen Mikrobiol Virusol; 1987 May; (5):44-6. PubMed ID: 3112564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pushing the envelope: LPS modifications and their consequences.
    Simpson BW; Trent MS
    Nat Rev Microbiol; 2019 Jul; 17(7):403-416. PubMed ID: 31142822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of porcine ficolin-alpha to lipopolysaccharides from Gram-negative bacteria and lipoteichoic acids from Gram-positive bacteria.
    Nahid AM; Sugii S
    Dev Comp Immunol; 2006; 30(3):335-43. PubMed ID: 15964070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria.
    Munford RS; Varley AW
    PLoS Pathog; 2006 Jun; 2(6):e67. PubMed ID: 16846256
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds.
    Heumann D; Lauener R; Ryffel B
    J Endotoxin Res; 2003; 9(6):381-4. PubMed ID: 14733725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic homology among gram-negative organisms isolated from cattle with clinical mastitis.
    Tyler J; Spears H; Cullor J; Smith W; Nelson R; Martin J
    J Dairy Sci; 1991 Apr; 74(4):1235-42. PubMed ID: 1907303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Condie RM; Cerra FB
    Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxins: lipopolysaccharides of gram-negative bacteria.
    Wang X; Quinn PJ
    Subcell Biochem; 2010; 53():3-25. PubMed ID: 20593260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide (LPS) from the cellular wall of Gram-negative bacteria, also known as endotoxin, is a key molecule in the pathogenesis of sepsis and septic shock. Preface.
    Ronco C
    Blood Purif; 2014; 37 Suppl 1():1. PubMed ID: 24457486
    [No Abstract]   [Full Text] [Related]  

  • 20. Delivery of dangerous goods: type III secretion in enteric pathogens.
    Zaharik ML; Gruenheid S; Perrin AJ; Finlay BB
    Int J Med Microbiol; 2002 Mar; 291(8):593-603. PubMed ID: 12008913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.